Bipolar disorder, also known as manic-depressive disorder, is a combination of manic, hypomanic and depressive episodes.The ultimate goal of therapeutic agents for bipolar disorder is to improve patients' quality of life and maintain good social function as much as possible.
This report contains market size and forecasts of Bipolar Disorder Therapeutics Drugs in global, including the following market information:
Global Bipolar Disorder Therapeutics Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bipolar Disorder Therapeutics Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bipolar Disorder Therapeutics Drugs companies in 2021 (%)
The global Bipolar Disorder Therapeutics Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Olanzapine (Zyprexa) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bipolar Disorder Therapeutics Drugs include AstraZeneca, Allergan, Bristol-Myers Squibb, GSK, Janssen, AbbVie, Youdim, Delpor and Lundbeck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bipolar Disorder Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bipolar Disorder Therapeutics Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bipolar Disorder Therapeutics Drugs Market Segment Percentages, by Type, 2021 (%)
Olanzapine (Zyprexa)
Quetiapine (Seroquel)
Risperidone (Risperdal)
Ariprazole (Abilify)
Ziprasidone (Geodon)
Clozapine (Clozaril)
Global Bipolar Disorder Therapeutics Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bipolar Disorder Therapeutics Drugs Market Segment Percentages, by Application, 2021 (%)
lumateperone
Central Nervous System (CNS) Disorders
Global Bipolar Disorder Therapeutics Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bipolar Disorder Therapeutics Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bipolar Disorder Therapeutics Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bipolar Disorder Therapeutics Drugs revenues share in global market, 2021 (%)
Key companies Bipolar Disorder Therapeutics Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bipolar Disorder Therapeutics Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Allergan
Bristol-Myers Squibb
GSK
Janssen
AbbVie
Youdim
Delpor
Lundbeck
Intra-Cellular Therapies
Novartis Pharmaceuticals Corporation
Noven Pharmaceuticals
Otsuka
Pfizer
Reviva Pharmaceuticals